A detailed history of First Manhattan CO transactions in Cerus Corp stock. As of the latest transaction made, First Manhattan CO holds 57,000 shares of CERS stock, worth $102,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,000
Previous 57,000 -0.0%
Holding current value
$102,030
Previous $100,000 1.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.79 - $2.9 $8,950 - $14,500
-5,000 Reduced 8.06%
57,000 $140,000
Q3 2018

Oct 15, 2018

BUY
$6.89 - $7.78 $137,800 - $155,600
20,000 Added 47.62%
62,000 $447,000
Q3 2017

Oct 25, 2017

BUY
$2.22 - $2.73 $93,240 - $114,660
42,000
42,000 $114,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.